🔺Significant breakthrough in medicine; an American company’s cancer vaccine reduces the risk of recurrence and spread of melanoma; Moderna’s stock value surged sharply

◾The American company Moderna announced on Wednesday that a personalized, cancer vaccine based on mRNA technology succeeded in a Phase 3 clinical trial in reducing the risk of the recurrence and spread of skin cancer of the melanoma type.

Hashtags: ["VOA Persian"]